Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
SensDx logo — Fast Precise and Ultrasensitive Digital Diagnostics Tests

SensDx

Fast Precise and Ultrasensitive Digital Diagnostics Tests

Founded 2014 Poland Poland 10 employees Biotechnology, Health Care

General Information

Company Name SensDx
Founded Year 2014
Location Poland Poland +1
Employees 10
Industries Biotechnology, Health Care
Social

Get notified when SensDx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SensDx

SensDx is a Polish startup operating in the telemedicine sector, with a focus on creating digital diagnostic testing technologies for both people and animals. The company's innovative solution revolves around a simple tool based on a fast, ultra-sensitive diagnostic test, complemented by a mobile application for easy result interpretation. These test tools are housed in specially-designed devices named Mobi for individual patients and Pro for medical professionals. Founded in 2014, SensDx has set out to revolutionize global telemedicine by offering accurate, fast, and user-friendly tests for detecting specific illnesses. The company's mission is to provide precise test results and diagnostic support to add value for both doctors and patients, with the vision of advancing telemedicine in a significant way. The company's key focus areas are in the industries of Biotechnology and Health Care. As of now, there is no publicly disclosed information about last investment or investors. With its strong emphasis on innovation and addressing critical needs in telemedicine, SensDx presents an intriguing potential for investment within the burgeoning healthcare technology sector.

Taxonomy: telemedicine, diagnostic testing, digital diagnostics, mobile application, home testing, ultrasensitive tests, disease identification, telehealth, medical innovation

No funding data available for SensDx yet.

Get notified when SensDx raises funding

SensDx Alternatives & Competitors

SensDx vs
SQI Diagnostics
SQI Diagnostics Canada

Our commitment is to improve lives by leveraging our cutting-edge technology to create innovative di...

Post Ipo Equity
28 employees
Biotechnology
SensDx vs
InnaMed
InnaMed

Experience convenient at-home blood testing with advanced DNA-driven assays and cloud-based analytic...

Series Unknown
Health Care, Medical Devices
SensDx vs
Pathnostics - A Diagnostics Solutions Company
Pathnostics - A Diagnostics Solutions Company United States

We pioneer approaches for better patient care and empower physicians to champion patient health toda...

Private Equity
171 employees
Biotechnology, Health Care

FAQ About SensDx

Fast Precise and Ultrasensitive Digital Diagnostics Tests
SensDx was founded in 2014.
SensDx is headquartered in Poland.
SensDx operates in the following industries: Biotechnology, Health Care.
SensDx has approximately 10 employees.
Top alternatives and competitors to SensDx include SQI Diagnostics, InnaMed, Pathnostics - A Diagnostics Solutions Company, Lincoln Diagnostics , LLC, Lyfstone. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SensDx and SQI Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SensDx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy